Previous close | 155.18 |
Open | 156.00 |
Bid | 156.90 x 7500 |
Ask | 157.70 x 7400 |
Day's range | 154.76 - 157.90 |
52-week range | 135.28 - 185.00 |
Volume | |
Avg. volume | 89 |
Market cap | 72.364B |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | 32.57 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.62 (1.05%) |
Ex-dividend date | 18 Apr 2024 |
1y target est | N/A |
PARSIPPANY, N.J., May 02, 2024--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2024 and updated its guidance for full year 2024.
PARSIPPANY, N.J. & TEANECK, N.J., April 28, 2024--Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.
PARSIPPANY, N.J., April 25, 2024--As we celebrate World Veterinary Day, the Zoetis Foundation is proud to support veterinarians around the world today and everyday by providing grant support to initiatives promoting veterinary education, mental well-being, and livelihoods. Recognizing the invaluable role veterinarians and veterinary technicians play in advancing animal health, the Foundation is committed to helping cultivate a thriving, inclusive veterinary profession.